Lori Ann Richardson

Title: Lori Ann Richardson: Innovator in Pharmaceutical Science

Introduction

Lori Ann Richardson is a prominent inventor based in Indianapolis, IN (US). She has made significant contributions to the field of pharmaceutical science, particularly in the development of innovative compounds that target specific biological pathways. With a total of 3 patents to her name, Richardson's work has the potential to impact therapeutic strategies for various diseases.

Latest Patents

Among her latest inventions is a Protein Kinase C inhibitor. This invention provides novel bis-indolylmaleimide macrocycle derivatives and solvates thereof. The invention further details the preparation, pharmaceutical formulations, and methods of use for inhibiting Protein Kinase C in mammals. This innovative approach could lead to new treatments for conditions influenced by this critical enzyme.

Career Highlights

Lori Ann Richardson is currently employed at Eli Lilly and Company, a leading global pharmaceutical company. Her role involves extensive research and development, focusing on creating effective therapeutic solutions. Her expertise in the field has positioned her as a valuable asset to her team and the broader scientific community.

Collaborations

Richardson has collaborated with notable colleagues, including Gary Lowell Engel and Nagy Alphonse Farid. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries.

Conclusion

Lori Ann Richardson's contributions to pharmaceutical science exemplify the impact of innovative thinking in medicine. Her patents and ongoing research continue to pave the way for advancements in therapeutic options.